Evidence map›Paper›PMID 32134263›Full record

ArticleJournal of medicinal chemistry2020

Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids.

Jianbo Wu, Xiaofang Wang, Francis C K Chiu, Cécile Häberli, David M Shackleford, Eileen Ryan, Sriraghavan Kamaraj, Vivek J Bulbule, Alexander I Wallick, Yuxiang Dong and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Antischistosomal Ozonide Glycine Ethyl Esters.ACS medicinal chemistry letters · 2026
    Article
  2. Old drugs, new weapons: current trends in repurposing therapies against antimicrobial resistance.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Review
  3. Review
  4. Review
  5. Bridged 1,2,4-Trioxolanes: SnClMolecules (Basel, Switzerland) · 2023
    Article
  6. ACS infectious diseases · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Criegee Intermediates Beyond Ozonolysis: Synthetic and Mechanistic Insights.Angewandte Chemie (International ed. in English) · 2021
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Jianbo WuCollege of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.
Xiaofang WangCollege of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.
Francis C K ChiuCentre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.
Cécile HäberliSwiss Tropical and Public Health Institute, Socinstrasse 57, CH-4002 Basel, Switzerland.
David M ShacklefordCentre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.
Eileen RyanCentre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.
Sriraghavan KamarajCollege of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.
Vivek J BulbuleCollege of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.
Alexander I WallickDepartment of Biology, University of Nebraska at Omaha, Omaha, Nebraska 68182, United States.
Yuxiang DongCollege of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.ORCID 0000-0003-1412-3178
Karen L WhiteCentre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.
Paul H DavisDepartment of Biology, University of Nebraska at Omaha, Omaha, Nebraska 68182, United States.ORCID 0000-0002-0526-3841
Susan A CharmanCentre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.
Jennifer KeiserSwiss Tropical and Public Health Institute, Socinstrasse 57, CH-4002 Basel, Switzerland.ORCID 0000-0003-0290-3521
Jonathan L VennerstromCollege of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.ORCID 0000-0003-0075-2336
Nebraska Medical Center · USMonash University · AUSwiss Tropical and Public Health Institute · CHUniversity of Nebraska at Omaha · US

Funding

Optimization of Antischistosomal ChemotypesR01AI116723 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI VENNERSTROM, JONATHAN L · 2015 to 2024
$6.2M
NIAID NIH HHS R01 AI116723
6 · The paper itself

Abstract

Semisynthetic artemisinins and other bioactive peroxides are best known for their powerful antimalarial activities, and they also show substantial activity against schistosomes-another hemoglobin-degrading pathogen. Building on this discovery, we now describe the initial structure-activity relationship (SAR) of antischistosomal ozonide carboxylic acids OZ418 (

Indexed as

AdamantaneAnimalsCarboxylic AcidsCell Line, TumorFemaleHEK293 CellsHeterocyclic Compounds, 1-RingHumansMiceMolecular StructureParasitic Sensitivity TestsSchistosoma mansoniSchistosomiasis mansoniSchistosomicidesSpiro CompoundsStructure-Activity RelationshipAdamantaneCarboxylic AcidsHeterocyclic Compounds, 1-RingSchistosomicidesSpiro Compounds

Identifiers

PMID32134263
PMCPMC7182039
OpenAlexW3009257532

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.